

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.78592466 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.78592466 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.29584487 |
| 4 | cellular potassium ion homeostasis (GO:0030007) | 4.66440073 |
| 5 | sodium ion export (GO:0071436) | 4.36943458 |
| 6 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.34445274 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.18325326 |
| 8 | glutamate secretion (GO:0014047) | 4.09549977 |
| 9 | axon ensheathment (GO:0008366) | 3.96747047 |
| 10 | ensheathment of neurons (GO:0007272) | 3.96747047 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.94941090 |
| 12 | myelination (GO:0042552) | 3.91631148 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.85903101 |
| 14 | cerebellar granule cell differentiation (GO:0021707) | 3.82720630 |
| 15 | creatine metabolic process (GO:0006600) | 3.82204551 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.74455253 |
| 17 | cell communication by electrical coupling (GO:0010644) | 3.71356485 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 3.66541154 |
| 19 | locomotory exploration behavior (GO:0035641) | 3.63430399 |
| 20 | potassium ion homeostasis (GO:0055075) | 3.62278245 |
| 21 | postsynaptic membrane organization (GO:0001941) | 3.51447762 |
| 22 | import into cell (GO:0098657) | 3.50102654 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.44163606 |
| 24 | response to methylmercury (GO:0051597) | 3.36680549 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.36598394 |
| 26 | neuronal ion channel clustering (GO:0045161) | 3.33460135 |
| 27 | vocalization behavior (GO:0071625) | 3.32045174 |
| 28 | cellular response to epinephrine stimulus (GO:0071872) | 3.29381511 |
| 29 | cellular sodium ion homeostasis (GO:0006883) | 3.28296242 |
| 30 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.27736827 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.27118868 |
| 32 | response to lipoprotein particle (GO:0055094) | 3.27011106 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.23483093 |
| 34 | L-amino acid import (GO:0043092) | 3.21273882 |
| 35 | photoreceptor cell differentiation (GO:0046530) | 3.19944823 |
| 36 | eye photoreceptor cell differentiation (GO:0001754) | 3.19944823 |
| 37 | regulation of sequestering of triglyceride (GO:0010889) | 3.15822450 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.15465575 |
| 39 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.14959592 |
| 40 | myelin maintenance (GO:0043217) | 3.14932257 |
| 41 | regulation of ARF protein signal transduction (GO:0032012) | 3.14910687 |
| 42 | presynaptic membrane organization (GO:0097090) | 3.13631595 |
| 43 | neurotransmitter secretion (GO:0007269) | 3.13310327 |
| 44 | peripheral nervous system axon ensheathment (GO:0032292) | 3.07258609 |
| 45 | myelination in peripheral nervous system (GO:0022011) | 3.07258609 |
| 46 | negative regulation of protein localization to cell surface (GO:2000009) | 3.05164755 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.03160931 |
| 48 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02349059 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.01195254 |
| 50 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.99518449 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 2.97132040 |
| 52 | cell communication involved in cardiac conduction (GO:0086065) | 2.95917454 |
| 53 | neuron cell-cell adhesion (GO:0007158) | 2.93780747 |
| 54 | response to epinephrine (GO:0071871) | 2.92177449 |
| 55 | neuromuscular process controlling balance (GO:0050885) | 2.90426789 |
| 56 | cardiac myofibril assembly (GO:0055003) | 2.89873292 |
| 57 | myofibril assembly (GO:0030239) | 2.86191416 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 2.85883036 |
| 59 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.85473772 |
| 60 | synaptic transmission, glutamatergic (GO:0035249) | 2.83849684 |
| 61 | fatty acid elongation (GO:0030497) | 2.82994467 |
| 62 | nerve growth factor signaling pathway (GO:0038180) | 2.82018460 |
| 63 | exploration behavior (GO:0035640) | 2.81949893 |
| 64 | sarcomere organization (GO:0045214) | 2.80712944 |
| 65 | axonal fasciculation (GO:0007413) | 2.80408150 |
| 66 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.79081540 |
| 67 | asymmetric protein localization (GO:0008105) | 2.73952296 |
| 68 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.73225611 |
| 69 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.72024175 |
| 70 | activation of protein kinase A activity (GO:0034199) | 2.71602888 |
| 71 | neuronal action potential propagation (GO:0019227) | 2.71281374 |
| 72 | neuron recognition (GO:0008038) | 2.70051125 |
| 73 | regulation of cardioblast differentiation (GO:0051890) | 2.67171550 |
| 74 | membrane tubulation (GO:0097320) | 2.66584118 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 2.66136707 |
| 76 | adult heart development (GO:0007512) | 2.65771999 |
| 77 | auditory behavior (GO:0031223) | 2.65676857 |
| 78 | protein localization to synapse (GO:0035418) | 2.65449481 |
| 79 | astrocyte differentiation (GO:0048708) | 2.65326103 |
| 80 | regulation of synaptic plasticity (GO:0048167) | 2.65171321 |
| 81 | regulation of synapse structural plasticity (GO:0051823) | 2.64206535 |
| 82 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.62660020 |
| 83 | positive regulation of membrane potential (GO:0045838) | 2.59908777 |
| 84 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.59594185 |
| 85 | growth hormone receptor signaling pathway (GO:0060396) | 2.59218263 |
| 86 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.58001364 |
| 87 | membrane assembly (GO:0071709) | 2.57333030 |
| 88 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.57135095 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 2.56091037 |
| 90 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.54102332 |
| 91 | layer formation in cerebral cortex (GO:0021819) | 2.51833149 |
| 92 | neuron-neuron synaptic transmission (GO:0007270) | 2.51627429 |
| 93 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.51064072 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 2.50233357 |
| 95 | atrioventricular valve morphogenesis (GO:0003181) | 2.48984717 |
| 96 | cortical actin cytoskeleton organization (GO:0030866) | 2.48464987 |
| 97 | neurotransmitter transport (GO:0006836) | 2.48463966 |
| 98 | gamma-aminobutyric acid transport (GO:0015812) | 2.48109849 |
| 99 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.46781435 |
| 100 | regulation of synapse maturation (GO:0090128) | 2.46187308 |
| 101 | glycine transport (GO:0015816) | 2.46114917 |
| 102 | membrane depolarization during action potential (GO:0086010) | 2.45962778 |
| 103 | * embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.45762113 |
| 104 | apical protein localization (GO:0045176) | 2.45760255 |
| 105 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.45241756 |
| 106 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.44778789 |
| 107 | positive regulation of dendrite development (GO:1900006) | 2.44657270 |
| 108 | positive regulation of action potential (GO:0045760) | 2.44466993 |
| 109 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.43527073 |
| 110 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.43272646 |
| 111 | amino acid import (GO:0043090) | 2.43163506 |
| 112 | regulation of neurotransmitter secretion (GO:0046928) | 2.42602208 |
| 113 | regulation of postsynaptic membrane potential (GO:0060078) | 2.41943921 |
| 114 | detection of calcium ion (GO:0005513) | 2.41923605 |
| 115 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.41435744 |
| 116 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.41146699 |
| 117 | regulation of p38MAPK cascade (GO:1900744) | 2.41114993 |
| 118 | positive regulation of neurological system process (GO:0031646) | 2.40637570 |
| 119 | cellular response to catecholamine stimulus (GO:0071870) | 2.40468479 |
| 120 | cellular response to monoamine stimulus (GO:0071868) | 2.40468479 |
| 121 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.39624036 |
| 122 | regulation of dendritic spine development (GO:0060998) | 2.39375687 |
| 123 | oligodendrocyte differentiation (GO:0048709) | 2.38110259 |
| 124 | cell differentiation in hindbrain (GO:0021533) | 2.37780888 |
| 125 | histone H3-K4 trimethylation (GO:0080182) | 2.37780593 |
| 126 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.37709169 |
| 127 | long-term memory (GO:0007616) | 2.37339797 |
| 128 | neurotransmitter uptake (GO:0001504) | 2.37068325 |
| 129 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.36220191 |
| 130 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.35770646 |
| 131 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.35037193 |
| 132 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.34075706 |
| 133 | acidic amino acid transport (GO:0015800) | 2.34055452 |
| 134 | relaxation of cardiac muscle (GO:0055119) | 2.33921829 |
| 135 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.29710220 |
| 136 | regulation of actin filament-based movement (GO:1903115) | 2.29544031 |
| 137 | regulation of lipoprotein metabolic process (GO:0050746) | 2.29395629 |
| 138 | glomerular filtration (GO:0003094) | 2.28313629 |
| 139 | carnitine shuttle (GO:0006853) | 2.28285594 |
| 140 | astrocyte development (GO:0014002) | 2.24879126 |
| 141 | negative regulation of neurotransmitter transport (GO:0051589) | 2.23742829 |
| 142 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.23102513 |
| 143 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.22489246 |
| 144 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.21723687 |
| 145 | triglyceride biosynthetic process (GO:0019432) | 2.20625012 |
| 146 | fatty acid transmembrane transport (GO:1902001) | 2.19655363 |
| 147 | positive regulation of fatty acid oxidation (GO:0046321) | 2.19497794 |
| 148 | positive regulation of p38MAPK cascade (GO:1900745) | 2.19479860 |
| 149 | dendritic spine morphogenesis (GO:0060997) | 2.18212373 |
| 150 | cortical cytoskeleton organization (GO:0030865) | 2.16718256 |
| 151 | response to catecholamine (GO:0071869) | 2.16564237 |
| 152 | response to monoamine (GO:0071867) | 2.16564237 |
| 153 | cellular response to growth hormone stimulus (GO:0071378) | 2.16207340 |
| 154 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.15482642 |
| 155 | neurotransmitter catabolic process (GO:0042135) | 2.14976586 |
| 156 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.13831322 |
| 157 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.13734073 |
| 158 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.13694443 |
| 159 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.13694443 |
| 160 | acylglycerol biosynthetic process (GO:0046463) | 2.13288676 |
| 161 | neutral lipid biosynthetic process (GO:0046460) | 2.13288676 |
| 162 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.13271205 |
| 163 | atrial septum morphogenesis (GO:0060413) | 2.12458340 |
| 164 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.12354004 |
| 165 | thioester biosynthetic process (GO:0035384) | 2.11999847 |
| 166 | acyl-CoA biosynthetic process (GO:0071616) | 2.11999847 |
| 167 | regulation of somitogenesis (GO:0014807) | 2.11312378 |
| 168 | protein targeting to Golgi (GO:0000042) | 2.10604710 |
| 169 | dendrite morphogenesis (GO:0048813) | 2.10302601 |
| 170 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.09927585 |
| 171 | camera-type eye morphogenesis (GO:0048593) | 2.09762694 |
| 172 | potassium ion import (GO:0010107) | 2.09196977 |
| 173 | actomyosin structure organization (GO:0031032) | 2.08860084 |
| 174 | plasma membrane repair (GO:0001778) | 2.08107688 |
| 175 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.06540274 |
| 176 | nucleus localization (GO:0051647) | 2.06312653 |
| 177 | semaphorin-plexin signaling pathway (GO:0071526) | 2.04865128 |
| 178 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.04491293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.28591395 |
| 2 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.18314527 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.16703792 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.16472310 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10470598 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.06021428 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01355380 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.84618219 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83233709 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.75434404 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.74486642 |
| 12 | GATA1_19941826_ChIP-Seq_K562_Human | 1.69099903 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68335485 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67555747 |
| 15 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.67118423 |
| 16 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64218906 |
| 17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.64009900 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63359924 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62326488 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62326488 |
| 21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.57341428 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56287226 |
| 23 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54979396 |
| 24 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54594886 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.54449750 |
| 26 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.53131854 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52786446 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49029122 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46596010 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41205655 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.40855356 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39898947 |
| 33 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38295029 |
| 34 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.37830478 |
| 35 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36268248 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34943399 |
| 37 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34443008 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34205943 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33969396 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33330512 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31790369 |
| 42 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31107119 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31102341 |
| 44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.30710862 |
| 45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.30710862 |
| 46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.29882422 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29311911 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27983268 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27857906 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27527911 |
| 51 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26270909 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25772635 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25745554 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24539997 |
| 55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24521044 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23752931 |
| 57 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.23195386 |
| 58 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.23020400 |
| 59 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.23008481 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21567184 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21264521 |
| 62 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21257187 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20386548 |
| 64 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20276864 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20053725 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19174024 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18571510 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16603959 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14351306 |
| 70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13918002 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13007279 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12736991 |
| 73 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12694378 |
| 74 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12633756 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12301819 |
| 76 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11771857 |
| 77 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.11483408 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11318038 |
| 79 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10761199 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10697167 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10558243 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09775306 |
| 83 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08995533 |
| 84 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07984652 |
| 85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07391696 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05515658 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05343347 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04342487 |
| 89 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03608559 |
| 90 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03141631 |
| 91 | AR_19668381_ChIP-Seq_PC3_Human | 1.02908617 |
| 92 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02718803 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02673993 |
| 94 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01225194 |
| 95 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01160960 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00208897 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99930280 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97424496 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97399312 |
| 100 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97354660 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96498272 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96441101 |
| 103 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95367711 |
| 104 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95035289 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94976055 |
| 106 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94873749 |
| 107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94773854 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94698160 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94300558 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94066849 |
| 111 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.93753982 |
| 112 | TBL1_22424771_ChIP-Seq_293T_Human | 0.93661799 |
| 113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93348274 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93257580 |
| 115 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93110040 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92709486 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92581006 |
| 118 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91766888 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91495610 |
| 120 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91419399 |
| 121 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91090068 |
| 122 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90556550 |
| 123 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90306977 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88031286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.42712739 |
| 2 | MP0004185_abnormal_adipocyte_glucose | 3.34930887 |
| 3 | MP0000920_abnormal_myelination | 3.33072090 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.29355769 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.27685222 |
| 6 | MP0005670_abnormal_white_adipose | 3.22938754 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.14892873 |
| 8 | MP0003880_abnormal_central_pattern | 3.02569705 |
| 9 | MP0005666_abnormal_adipose_tissue | 3.00378660 |
| 10 | MP0004130_abnormal_muscle_cell | 2.85384760 |
| 11 | MP0003690_abnormal_glial_cell | 2.80682222 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.59289320 |
| 13 | MP0004147_increased_porphyrin_level | 2.59128782 |
| 14 | MP0003646_muscle_fatigue | 2.46637255 |
| 15 | MP0005375_adipose_tissue_phenotype | 2.40118014 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.31599098 |
| 17 | MP0009745_abnormal_behavioral_response | 2.31518301 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.23066901 |
| 19 | MP0000751_myopathy | 2.21927703 |
| 20 | MP0008775_abnormal_heart_ventricle | 2.19196147 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.14840449 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.12918970 |
| 23 | MP0004215_abnormal_myocardial_fiber | 2.10899286 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 2.07278559 |
| 25 | MP0003879_abnormal_hair_cell | 2.03419913 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.00841620 |
| 27 | MP0000749_muscle_degeneration | 1.96560753 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.90255977 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.88046546 |
| 30 | MP0003137_abnormal_impulse_conducting | 1.86844535 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.84351736 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.82508025 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.72918478 |
| 34 | MP0002971_abnormal_brown_adipose | 1.71992689 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.70566204 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.67775142 |
| 37 | MP0005409_darkened_coat_color | 1.67248936 |
| 38 | MP0005620_abnormal_muscle_contractility | 1.65434981 |
| 39 | MP0005330_cardiomyopathy | 1.62825434 |
| 40 | MP0004270_analgesia | 1.60269471 |
| 41 | MP0006138_congestive_heart_failure | 1.56634724 |
| 42 | MP0003634_abnormal_glial_cell | 1.56031965 |
| 43 | MP0010630_abnormal_cardiac_muscle | 1.54802629 |
| 44 | MP0001970_abnormal_pain_threshold | 1.54016300 |
| 45 | MP0001299_abnormal_eye_distance/ | 1.51521250 |
| 46 | MP0003122_maternal_imprinting | 1.48681595 |
| 47 | MP0001984_abnormal_olfaction | 1.48577436 |
| 48 | MP0000955_abnormal_spinal_cord | 1.47887273 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.46721600 |
| 50 | MP0001486_abnormal_startle_reflex | 1.45465315 |
| 51 | * MP0002067_abnormal_sensory_capabilities | 1.45255947 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.44330310 |
| 53 | MP0005385_cardiovascular_system_phenoty | 1.43813550 |
| 54 | MP0001544_abnormal_cardiovascular_syste | 1.43813550 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.43533662 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.42759761 |
| 57 | MP0001440_abnormal_grooming_behavior | 1.38595399 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.38138603 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.36068796 |
| 60 | MP0004085_abnormal_heartbeat | 1.35415865 |
| 61 | MP0000383_abnormal_hair_follicle | 1.31027337 |
| 62 | MP0000778_abnormal_nervous_system | 1.28997126 |
| 63 | MP0004742_abnormal_vestibular_system | 1.28638061 |
| 64 | * MP0002066_abnormal_motor_capabilities/c | 1.25090946 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.24629748 |
| 66 | MP0003283_abnormal_digestive_organ | 1.24128537 |
| 67 | MP0000747_muscle_weakness | 1.22531134 |
| 68 | MP0002909_abnormal_adrenal_gland | 1.20848815 |
| 69 | MP0000733_abnormal_muscle_development | 1.19788920 |
| 70 | MP0002106_abnormal_muscle_physiology | 1.17983630 |
| 71 | MP0002090_abnormal_vision | 1.17879218 |
| 72 | MP0008438_abnormal_cutaneous_collagen | 1.17735595 |
| 73 | MP0004885_abnormal_endolymph | 1.16243025 |
| 74 | MP0000759_abnormal_skeletal_muscle | 1.15977347 |
| 75 | MP0003045_fibrosis | 1.15791487 |
| 76 | MP0001529_abnormal_vocalization | 1.15743773 |
| 77 | MP0002152_abnormal_brain_morphology | 1.13625502 |
| 78 | MP0002184_abnormal_innervation | 1.12378570 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.11905452 |
| 80 | MP0005451_abnormal_body_composition | 1.10692444 |
| 81 | MP0003828_pulmonary_edema | 1.10338571 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.09845450 |
| 83 | MP0000462_abnormal_digestive_system | 1.08621725 |
| 84 | MP0001177_atelectasis | 1.07539102 |
| 85 | MP0003329_amyloid_beta_deposits | 1.06847786 |
| 86 | MP0006276_abnormal_autonomic_nervous | 1.06371450 |
| 87 | MP0003632_abnormal_nervous_system | 1.04778728 |
| 88 | MP0005369_muscle_phenotype | 1.04180051 |
| 89 | MP0009840_abnormal_foam_cell | 1.04029192 |
| 90 | MP0001661_extended_life_span | 1.03126960 |
| 91 | MP0005623_abnormal_meninges_morphology | 1.03072989 |
| 92 | MP0005334_abnormal_fat_pad | 1.02110256 |
| 93 | MP0008569_lethality_at_weaning | 1.01057726 |
| 94 | MP0002229_neurodegeneration | 1.00439894 |
| 95 | MP0004510_myositis | 0.99854124 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.98845919 |
| 97 | MP0004233_abnormal_muscle_weight | 0.98109715 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.97597014 |
| 99 | MP0005083_abnormal_biliary_tract | 0.95146595 |
| 100 | MP0005386_behavior/neurological_phenoty | 0.94668861 |
| 101 | MP0004924_abnormal_behavior | 0.94668861 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93289680 |
| 103 | MP0004272_abnormal_basement_membrane | 0.93262694 |
| 104 | MP0004043_abnormal_pH_regulation | 0.92987833 |
| 105 | MP0000566_synostosis | 0.92104824 |
| 106 | MP0009115_abnormal_fat_cell | 0.89837599 |
| 107 | MP0004484_altered_response_of | 0.89692366 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.89690147 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.88821380 |
| 110 | MP0005171_absent_coat_pigmentation | 0.87926390 |
| 111 | MP0003300_gastrointestinal_ulcer | 0.86770758 |
| 112 | MP0004859_abnormal_synaptic_plasticity | 0.86753601 |
| 113 | MP0000534_abnormal_ureter_morphology | 0.86701691 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.85613647 |
| 115 | MP0002736_abnormal_nociception_after | 0.85379822 |
| 116 | MP0005448_abnormal_energy_balance | 0.83013922 |
| 117 | MP0005248_abnormal_Harderian_gland | 0.82472265 |
| 118 | MP0002064_seizures | 0.81914383 |
| 119 | MP0003091_abnormal_cell_migration | 0.80468478 |
| 120 | MP0002272_abnormal_nervous_system | 0.80154776 |
| 121 | MP0005535_abnormal_body_temperature | 0.78515117 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.78278054 |
| 123 | MP0003937_abnormal_limbs/digits/tail_de | 0.78212741 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.78179892 |
| 125 | MP0002108_abnormal_muscle_morphology | 0.77760076 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.77444663 |
| 127 | MP0003123_paternal_imprinting | 0.76712048 |
| 128 | MP0001958_emphysema | 0.76666594 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.76035261 |
| 130 | MP0003631_nervous_system_phenotype | 0.75789689 |
| 131 | MP0001905_abnormal_dopamine_level | 0.75236365 |
| 132 | MP0004858_abnormal_nervous_system | 0.74487491 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.73315102 |
| 134 | MP0003172_abnormal_lysosome_physiology | 0.73307750 |
| 135 | MP0009384_cardiac_valve_regurgitation | 0.73300720 |
| 136 | MP0002269_muscular_atrophy | 0.73074560 |
| 137 | MP0005195_abnormal_posterior_eye | 0.72763217 |
| 138 | MP0000266_abnormal_heart_morphology | 0.72184386 |
| 139 | MP0002882_abnormal_neuron_morphology | 0.71800345 |
| 140 | MP0008874_decreased_physiological_sensi | 0.71237859 |
| 141 | MP0000579_abnormal_nail_morphology | 0.70368047 |
| 142 | MP0009046_muscle_twitch | 0.69899368 |
| 143 | MP0002822_catalepsy | 0.69203466 |
| 144 | MP0003633_abnormal_nervous_system | 0.68257338 |
| 145 | * MP0003861_abnormal_nervous_system | 0.66218878 |
| 146 | MP0002069_abnormal_eating/drinking_beha | 0.64760732 |
| 147 | MP0002249_abnormal_larynx_morphology | 0.64425430 |
| 148 | MP0003868_abnormal_feces_composition | 0.64293726 |
| 149 | MP0001348_abnormal_lacrimal_gland | 0.63914371 |
| 150 | MP0004142_abnormal_muscle_tone | 0.63566110 |
| 151 | MP0000026_abnormal_inner_ear | 0.62688024 |
| 152 | MP0001943_abnormal_respiration | 0.62686734 |
| 153 | MP0002082_postnatal_lethality | 0.62588695 |
| 154 | MP0010770_preweaning_lethality | 0.62588695 |
| 155 | MP0000631_abnormal_neuroendocrine_gland | 0.62452334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.41445759 |
| 2 | Obstructive sleep apnea (HP:0002870) | 4.18171295 |
| 3 | Focal motor seizures (HP:0011153) | 4.17793426 |
| 4 | Hyporeflexia of lower limbs (HP:0002600) | 4.13247340 |
| 5 | Muscle fiber splitting (HP:0003555) | 4.09864907 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.92152853 |
| 7 | Sudden death (HP:0001699) | 3.81435527 |
| 8 | Focal seizures (HP:0007359) | 3.72076961 |
| 9 | Difficulty running (HP:0009046) | 3.68461534 |
| 10 | Febrile seizures (HP:0002373) | 3.59728525 |
| 11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.50457676 |
| 12 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.50457676 |
| 13 | Increased circulating renin level (HP:0000848) | 3.31494840 |
| 14 | Abnormality of binocular vision (HP:0011514) | 3.30026846 |
| 15 | Diplopia (HP:0000651) | 3.30026846 |
| 16 | Prolonged QT interval (HP:0001657) | 3.24606860 |
| 17 | Atrial fibrillation (HP:0005110) | 3.21403176 |
| 18 | Ventricular tachycardia (HP:0004756) | 3.18102157 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.16348494 |
| 20 | Calf muscle hypertrophy (HP:0008981) | 3.11411650 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 3.11163835 |
| 22 | Atonic seizures (HP:0010819) | 3.10695124 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.02517176 |
| 24 | Poikilocytosis (HP:0004447) | 2.93980198 |
| 25 | Onion bulb formation (HP:0003383) | 2.92352937 |
| 26 | Macroorchidism (HP:0000053) | 2.90229965 |
| 27 | Ankle clonus (HP:0011448) | 2.88559728 |
| 28 | Primary atrial arrhythmia (HP:0001692) | 2.87527179 |
| 29 | Subaortic stenosis (HP:0001682) | 2.81148147 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.81148147 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 2.77117658 |
| 32 | Slow saccadic eye movements (HP:0000514) | 2.73355836 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 2.71364954 |
| 34 | Lipoatrophy (HP:0100578) | 2.62395794 |
| 35 | Bronchomalacia (HP:0002780) | 2.61202289 |
| 36 | Supraventricular tachycardia (HP:0004755) | 2.60229576 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 2.59239107 |
| 38 | Supraventricular arrhythmia (HP:0005115) | 2.55632474 |
| 39 | Intention tremor (HP:0002080) | 2.51023434 |
| 40 | Premature skin wrinkling (HP:0100678) | 2.49711451 |
| 41 | Exercise-induced myalgia (HP:0003738) | 2.48966889 |
| 42 | Truncal ataxia (HP:0002078) | 2.47464620 |
| 43 | Hypoplastic ischia (HP:0003175) | 2.47450956 |
| 44 | Abnormality of the corticospinal tract (HP:0002492) | 2.46471207 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43928643 |
| 46 | Sensory axonal neuropathy (HP:0003390) | 2.41881158 |
| 47 | Axonal loss (HP:0003447) | 2.39463385 |
| 48 | Acanthocytosis (HP:0001927) | 2.39031750 |
| 49 | Sleep apnea (HP:0010535) | 2.38185912 |
| 50 | Dysmetria (HP:0001310) | 2.35020166 |
| 51 | Abnormal eating behavior (HP:0100738) | 2.32310199 |
| 52 | Diaphragmatic weakness (HP:0009113) | 2.32268242 |
| 53 | Papilledema (HP:0001085) | 2.30757726 |
| 54 | Scanning speech (HP:0002168) | 2.29810613 |
| 55 | Generalized tonic-clonic seizures (HP:0002069) | 2.28270456 |
| 56 | Termporal pattern (HP:0011008) | 2.27912266 |
| 57 | Insidious onset (HP:0003587) | 2.27912266 |
| 58 | Abnormality of the fingertips (HP:0001211) | 2.26745261 |
| 59 | Dysmetric saccades (HP:0000641) | 2.24484215 |
| 60 | Action tremor (HP:0002345) | 2.23557428 |
| 61 | Hemiplegia (HP:0002301) | 2.23542854 |
| 62 | Clumsiness (HP:0002312) | 2.23409838 |
| 63 | Absence seizures (HP:0002121) | 2.22120179 |
| 64 | Central scotoma (HP:0000603) | 2.21912886 |
| 65 | Abnormal auditory evoked potentials (HP:0006958) | 2.20124788 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.19263022 |
| 67 | Syncope (HP:0001279) | 2.18412261 |
| 68 | Spastic gait (HP:0002064) | 2.17869718 |
| 69 | Hemiparesis (HP:0001269) | 2.16207899 |
| 70 | EMG: myopathic abnormalities (HP:0003458) | 2.15714801 |
| 71 | Bundle branch block (HP:0011710) | 2.13924976 |
| 72 | Scapular winging (HP:0003691) | 2.13106315 |
| 73 | Dilated cardiomyopathy (HP:0001644) | 2.12431799 |
| 74 | Abnormality of the ischium (HP:0003174) | 2.11530928 |
| 75 | Metabolic alkalosis (HP:0200114) | 2.09952993 |
| 76 | Hyperacusis (HP:0010780) | 2.07275535 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.05889732 |
| 78 | Narrow palate (HP:0000189) | 2.02770598 |
| 79 | Overgrowth (HP:0001548) | 2.02646908 |
| 80 | Large for gestational age (HP:0001520) | 2.02422407 |
| 81 | Hypoplasia of the iris (HP:0007676) | 2.02271459 |
| 82 | Dialeptic seizures (HP:0011146) | 2.00760660 |
| 83 | Disproportionate tall stature (HP:0001519) | 2.00550139 |
| 84 | Shallow orbits (HP:0000586) | 1.99891192 |
| 85 | Hyperventilation (HP:0002883) | 1.96540764 |
| 86 | EEG with generalized epileptiform discharges (HP:0011198) | 1.96433022 |
| 87 | Depressed nasal tip (HP:0000437) | 1.96427187 |
| 88 | Gowers sign (HP:0003391) | 1.96269518 |
| 89 | Peripheral hypomyelination (HP:0007182) | 1.95771549 |
| 90 | Parakeratosis (HP:0001036) | 1.95545990 |
| 91 | Alacrima (HP:0000522) | 1.92923382 |
| 92 | Urethral obstruction (HP:0000796) | 1.92186783 |
| 93 | Dysdiadochokinesis (HP:0002075) | 1.92121154 |
| 94 | Lower limb muscle weakness (HP:0007340) | 1.90485548 |
| 95 | Genetic anticipation (HP:0003743) | 1.90422621 |
| 96 | Tracheomalacia (HP:0002779) | 1.87245585 |
| 97 | Pheochromocytoma (HP:0002666) | 1.85245766 |
| 98 | Broad metatarsal (HP:0001783) | 1.84790290 |
| 99 | Infantile muscular hypotonia (HP:0008947) | 1.84204248 |
| 100 | Torticollis (HP:0000473) | 1.84065233 |
| 101 | Urinary urgency (HP:0000012) | 1.80813795 |
| 102 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.80400416 |
| 103 | Vertebral arch anomaly (HP:0008438) | 1.80261304 |
| 104 | Drooling (HP:0002307) | 1.79552384 |
| 105 | Decreased lacrimation (HP:0000633) | 1.79308237 |
| 106 | Arterial tortuosity (HP:0005116) | 1.77941275 |
| 107 | Stereotypic behavior (HP:0000733) | 1.77301615 |
| 108 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.77036897 |
| 109 | Turricephaly (HP:0000262) | 1.76199504 |
| 110 | Widely spaced teeth (HP:0000687) | 1.76008100 |
| 111 | Depression (HP:0000716) | 1.75178816 |
| 112 | Hypsarrhythmia (HP:0002521) | 1.74681608 |
| 113 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74053069 |
| 114 | Abnormality of the foot musculature (HP:0001436) | 1.73661809 |
| 115 | Abnormal EKG (HP:0003115) | 1.73185999 |
| 116 | Anxiety (HP:0000739) | 1.72227985 |
| 117 | Foot dorsiflexor weakness (HP:0009027) | 1.71970851 |
| 118 | Abnormal atrioventricular conduction (HP:0005150) | 1.69938359 |
| 119 | Hypokalemic alkalosis (HP:0001949) | 1.68872811 |
| 120 | Bowel incontinence (HP:0002607) | 1.68864025 |
| 121 | Heart block (HP:0012722) | 1.68789779 |
| 122 | Long eyelashes (HP:0000527) | 1.68667283 |
| 123 | Cholelithiasis (HP:0001081) | 1.68417812 |
| 124 | Annular pancreas (HP:0001734) | 1.68405621 |
| 125 | Blue irides (HP:0000635) | 1.67108566 |
| 126 | Abnormal gallbladder morphology (HP:0012437) | 1.66452734 |
| 127 | Midline defect of the nose (HP:0004122) | 1.66151620 |
| 128 | Decreased motor nerve conduction velocity (HP:0003431) | 1.65792690 |
| 129 | Postural instability (HP:0002172) | 1.65638692 |
| 130 | Lower limb amyotrophy (HP:0007210) | 1.65621926 |
| 131 | Pulmonary artery stenosis (HP:0004415) | 1.65429063 |
| 132 | Limb dystonia (HP:0002451) | 1.65393507 |
| 133 | Anteriorly placed anus (HP:0001545) | 1.64693006 |
| 134 | Laryngomalacia (HP:0001601) | 1.64454417 |
| 135 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.64137462 |
| 136 | Aplasia involving bones of the extremities (HP:0009825) | 1.64065762 |
| 137 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.64065762 |
| 138 | Aplasia of the phalanges of the hand (HP:0009802) | 1.64065762 |
| 139 | Overriding aorta (HP:0002623) | 1.63368837 |
| 140 | Exercise-induced muscle cramps (HP:0003710) | 1.63325343 |
| 141 | Poor eye contact (HP:0000817) | 1.62097016 |
| 142 | Insomnia (HP:0100785) | 1.61941586 |
| 143 | Excessive salivation (HP:0003781) | 1.60824333 |
| 144 | Thickened helices (HP:0000391) | 1.60659051 |
| 145 | Myoglobinuria (HP:0002913) | 1.60041787 |
| 146 | Atrioventricular block (HP:0001678) | 1.59641772 |
| 147 | Coronal craniosynostosis (HP:0004440) | 1.59232794 |
| 148 | Rapidly progressive (HP:0003678) | 1.58784506 |
| 149 | Renovascular hypertension (HP:0100817) | 1.58600949 |
| 150 | Partial agenesis of the corpus callosum (HP:0001338) | 1.58337492 |
| 151 | Pigmentary retinal degeneration (HP:0001146) | 1.57817640 |
| 152 | Megalencephaly (HP:0001355) | 1.57783069 |
| 153 | Abnormal large intestine physiology (HP:0012700) | 1.57403763 |
| 154 | Hammertoe (HP:0001765) | 1.56098890 |
| 155 | Broad-based gait (HP:0002136) | 1.55402321 |
| 156 | Mask-like facies (HP:0000298) | 1.55018600 |
| 157 | Proximal amyotrophy (HP:0007126) | 1.54867301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1G | 3.78650820 |
| 2 | CAMK1D | 3.48112394 |
| 3 | NTRK3 | 3.22475412 |
| 4 | EPHB1 | 3.19235545 |
| 5 | STK39 | 3.17854179 |
| 6 | DMPK | 2.65710576 |
| 7 | PKN1 | 2.29959362 |
| 8 | CASK | 2.29042613 |
| 9 | EPHA4 | 2.27990585 |
| 10 | ICK | 2.09669687 |
| 11 | WNK1 | 2.06309670 |
| 12 | MAP3K9 | 1.90776396 |
| 13 | LATS1 | 1.84754909 |
| 14 | FGFR2 | 1.84128211 |
| 15 | PIK3CA | 1.75874499 |
| 16 | AKT3 | 1.73533920 |
| 17 | DAPK2 | 1.72573647 |
| 18 | WNK4 | 1.69846977 |
| 19 | PHKG2 | 1.68774825 |
| 20 | PHKG1 | 1.68774825 |
| 21 | SIK1 | 1.63937168 |
| 22 | TRIB3 | 1.61632223 |
| 23 | OXSR1 | 1.61611495 |
| 24 | LATS2 | 1.52649964 |
| 25 | MET | 1.52320068 |
| 26 | OBSCN | 1.52047918 |
| 27 | LMTK2 | 1.48478866 |
| 28 | CDK12 | 1.45517053 |
| 29 | RIPK1 | 1.45318037 |
| 30 | CAMKK1 | 1.43585813 |
| 31 | INSRR | 1.41447729 |
| 32 | TTN | 1.37290468 |
| 33 | SGK223 | 1.36479734 |
| 34 | SGK494 | 1.36479734 |
| 35 | MINK1 | 1.32017372 |
| 36 | BCR | 1.29806224 |
| 37 | MARK2 | 1.26674177 |
| 38 | PAK6 | 1.23315704 |
| 39 | PRKAA2 | 1.20519047 |
| 40 | ROCK2 | 1.18301503 |
| 41 | NTRK2 | 1.17187506 |
| 42 | TAOK3 | 1.15660186 |
| 43 | PRKD1 | 1.13154750 |
| 44 | CAMK1 | 1.12644141 |
| 45 | NTRK1 | 1.07375201 |
| 46 | PDGFRB | 1.06451948 |
| 47 | UHMK1 | 1.03073352 |
| 48 | IRAK2 | 1.02504795 |
| 49 | STK4 | 1.02335840 |
| 50 | STK38 | 1.02035800 |
| 51 | PAK3 | 1.01861223 |
| 52 | KSR2 | 0.98900106 |
| 53 | BRD4 | 0.93049978 |
| 54 | ERBB2 | 0.92451088 |
| 55 | PBK | 0.92409117 |
| 56 | MAP3K10 | 0.92235639 |
| 57 | PRKCH | 0.91580592 |
| 58 | SGK3 | 0.90522939 |
| 59 | CAMK2D | 0.88704503 |
| 60 | EPHB2 | 0.88559265 |
| 61 | DDR2 | 0.88351417 |
| 62 | ROCK1 | 0.87662497 |
| 63 | MTOR | 0.87642411 |
| 64 | TYRO3 | 0.85616696 |
| 65 | BMX | 0.84771975 |
| 66 | PRKAA1 | 0.83910618 |
| 67 | CLK1 | 0.83440207 |
| 68 | PRKD3 | 0.82413779 |
| 69 | PDPK1 | 0.80646748 |
| 70 | FGFR3 | 0.79671017 |
| 71 | CSNK1A1L | 0.78177087 |
| 72 | PTK2 | 0.78131202 |
| 73 | CDK9 | 0.78106566 |
| 74 | PRKCG | 0.77155924 |
| 75 | SGK1 | 0.75833768 |
| 76 | PRKCQ | 0.75780878 |
| 77 | STK11 | 0.75655370 |
| 78 | KSR1 | 0.75531801 |
| 79 | TNIK | 0.74826820 |
| 80 | CDC42BPA | 0.72793736 |
| 81 | MAP3K2 | 0.71892908 |
| 82 | ARAF | 0.71733133 |
| 83 | NUAK1 | 0.70654509 |
| 84 | TRPM7 | 0.69763155 |
| 85 | MAP3K13 | 0.69392845 |
| 86 | HIPK2 | 0.69362459 |
| 87 | MAPK13 | 0.68905965 |
| 88 | MAP3K4 | 0.68130470 |
| 89 | CAMK2G | 0.67286187 |
| 90 | CAMK2A | 0.67096806 |
| 91 | FGFR4 | 0.67055826 |
| 92 | MAPK12 | 0.66048719 |
| 93 | PLK2 | 0.65544470 |
| 94 | SIK2 | 0.65191635 |
| 95 | MAP3K7 | 0.64528782 |
| 96 | PTK6 | 0.64504985 |
| 97 | SGK2 | 0.63746924 |
| 98 | PDGFRA | 0.63263117 |
| 99 | CSNK1G1 | 0.62721557 |
| 100 | STK3 | 0.62039964 |
| 101 | TAOK1 | 0.61816405 |
| 102 | FYN | 0.60211383 |
| 103 | PRKD2 | 0.59372794 |
| 104 | PRKCZ | 0.58489226 |
| 105 | MELK | 0.57760179 |
| 106 | PRKG1 | 0.57720330 |
| 107 | PRKCE | 0.56451025 |
| 108 | EPHA3 | 0.56333319 |
| 109 | PNCK | 0.55685359 |
| 110 | PRPF4B | 0.54823886 |
| 111 | MAPKAPK5 | 0.54548835 |
| 112 | CDK5 | 0.53192806 |
| 113 | GSK3A | 0.51866273 |
| 114 | PDK1 | 0.51747432 |
| 115 | NEK6 | 0.51280388 |
| 116 | CDK15 | 0.51090199 |
| 117 | FGR | 0.50877831 |
| 118 | TNK2 | 0.50737394 |
| 119 | DYRK1A | 0.50408089 |
| 120 | IRAK1 | 0.50381835 |
| 121 | RPS6KA3 | 0.48685163 |
| 122 | MAP2K4 | 0.48623563 |
| 123 | CAMK4 | 0.48546737 |
| 124 | MOS | 0.48524514 |
| 125 | MAPK10 | 0.48489070 |
| 126 | STK10 | 0.47655524 |
| 127 | CDK18 | 0.47358041 |
| 128 | CSNK1G2 | 0.47267944 |
| 129 | PINK1 | 0.46917675 |
| 130 | JAK1 | 0.45751663 |
| 131 | CSNK1D | 0.43898484 |
| 132 | CAMK2B | 0.43632402 |
| 133 | RET | 0.41974636 |
| 134 | MARK1 | 0.41158164 |
| 135 | MUSK | 0.40964947 |
| 136 | PKN2 | 0.40553461 |
| 137 | CSNK1G3 | 0.40254666 |
| 138 | EEF2K | 0.40145121 |
| 139 | CDK11A | 0.40027108 |
| 140 | PRKACG | 0.39428057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21274919 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.49450957 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.30965846 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.23237552 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.90046990 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.85519572 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.85208784 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.79596779 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.76240650 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73212693 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 1.67640240 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59864687 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56539678 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54875596 |
| 15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.48028437 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.46066943 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.43217021 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40134869 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39945150 |
| 20 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35380533 |
| 21 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29936573 |
| 22 | Axon guidance_Homo sapiens_hsa04360 | 1.29077751 |
| 23 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.27772791 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23836354 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22272603 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18684526 |
| 27 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.17934933 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15840536 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14377692 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13493347 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13381178 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10652556 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08287644 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08146442 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07384610 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05062022 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.05007412 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04847882 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03272461 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.01885116 |
| 41 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01866577 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01329150 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94325838 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93245895 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92082631 |
| 46 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.91512222 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88963141 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88458820 |
| 49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86749020 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.86728453 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 0.85323436 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85264668 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84323194 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83932983 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83424585 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83325488 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82851971 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.82453768 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.82291264 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82093967 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79337418 |
| 62 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78897498 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78281440 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78255676 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77493165 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77087074 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.76893590 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75774192 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75354892 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.75296426 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74019493 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73716062 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73255527 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73222514 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.72596650 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72221496 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71357902 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71203771 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70608693 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69479631 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.69296156 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68342297 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68320117 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68266789 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67205797 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.66376856 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65256362 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63807656 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63659755 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63526246 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63474514 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62535493 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61365362 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.58682647 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58356037 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58223451 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.58140073 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.57487824 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57298364 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56931835 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54538684 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54395024 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.54318034 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53456315 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.53429363 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.53194320 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.52961977 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52694276 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52678413 |
| 110 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51504126 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50820524 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50812983 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50328483 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.49979387 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49467850 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48801699 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48675108 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48172881 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47729236 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47288975 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47041193 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46805060 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46432658 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.46362097 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45241021 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44733582 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.44004863 |
| 128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43395990 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43050157 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43012018 |
| 131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42322413 |
| 132 | Bile secretion_Homo sapiens_hsa04976 | 0.42309315 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41808373 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41674517 |

